<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01940614</url>
  </required_header>
  <id_info>
    <org_study_id>CODDI2013</org_study_id>
    <nct_id>NCT01940614</nct_id>
  </id_info>
  <brief_title>Use of Copeptin in Diabetes Insipidus</brief_title>
  <official_title>Use of Copeptin in the Differential Diagnosis of Diabetes insipidus-a Prospective International Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective evaluation of the novel biomarker copeptin in the differential diagnosis of
      diabetes insipidus against the standard diagnostic test methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose of this study is to compare the overall diagnostic accuracy of the three following
      diagnostic test procedures in diabetes insipidus (central, nephrogenic) and primary
      polydipsia: a) classical water deprivation test alone, b) classical water deprivation test
      plus plasma copeptin cut-off levels, c) hypertonic saline infusion test plus plasma copeptin
      measurement.

      The investigators hypothesize that firstly b) and c) is better as a). Secondly the
      investigators hypothesize that c) is non-inferior to b).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2013</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall diagnostic accuracy</measure>
    <time_frame>beginning and end of protocol, up to 9hours</time_frame>
    <description>Ratio of the number of correctly diagnosed patients to the number of all tested patients for the tests:
classical water deprivation test alone
classical water deprivation test plus plasma copeptin cut-off levels
hypertonic saline Infusion test plus plasma copeptin measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity, specificity, positive and negative predictive value</measure>
    <time_frame>beginning and end of protocol, up to 9hours</time_frame>
    <description>each diagnostic test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hoc best copeptin cut-off optimising overall performance</measure>
    <time_frame>beginning and end of protocol, up to 9hours</time_frame>
    <description>best copeptin cut-offs for differentiation between different diagnosis of polyuria-polydipsia syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>subjective burden as rated by patients on visual analogue scale</measure>
    <time_frame>beginning, during and end of protocol, up to 9hours</time_frame>
    <description>water deprivation test and hypertonic saline Infusion test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of specific anamnestic and clinical features</measure>
    <time_frame>before tests</time_frame>
    <description>Evaluation of anamnestic and clinical features to test-independently predict final diagnosis of polyuria-polydipsia syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of absent bright spot in posterior pituitary enlargement</measure>
    <time_frame>before or after tests</time_frame>
    <description>Evaluation of predictive value of absent bright spot in T1 weighted cranial MRI scans</description>
  </secondary_outcome>
  <enrollment type="Actual">156</enrollment>
  <condition>Diabetes Insipidus</condition>
  <condition>Primary Polydipsia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water deprivation test</intervention_name>
    <description>Classical water deprivation test alone</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water deprivation test</intervention_name>
    <description>classical water deprivation test plus plasma copeptin cut-off levels</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypertonic saline infusion</intervention_name>
    <description>hypertonic saline infusion test plus plasma copeptin measurement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Polyuria or/and Polydipsia or/and therapy with synthetic adenovirus proteinase (AVP)
             derivate

          -  Urine osmolality &lt;800mOsm/kgH20

        Exclusion Criteria:

          -  Polyuria due to diabetes mellitus

          -  Hypokalemia

          -  Hyperkalemia (&gt;5mmol/l)

          -  Hypercalcemia

          -  Kidney disease (min.: glomerular filtration rate (GFR) 60ml/min/1.73m2)

          -  Pregnancy

          -  Hyponatremia &gt;135mmol/L

          -  Hypernatremia &gt;145mmol/L

          -  Hypo- or hypervolemia

          -  uncorrected adrenal or thyroidal deficiency

          -  Cardia failure

          -  Epilepsia

          -  Uncontrolled hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mirjam Christ-Crain</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Univerisity Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2013</study_first_submitted>
  <study_first_submitted_qc>September 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2013</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Copeptin</keyword>
  <keyword>differential diagnosis of polyuria polydipsia syndrome</keyword>
  <keyword>diabetes insipidus</keyword>
  <keyword>compulsive water drinking</keyword>
  <keyword>water deprivation test</keyword>
  <keyword>Diabetes insipidus (central and nephrogenic)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Insipidus</mesh_term>
    <mesh_term>Polydipsia</mesh_term>
    <mesh_term>Polydipsia, Psychogenic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

